Febuxostat class of drug?

What class of drug is febuxostat?

Febuxostat (often spelled febuxostat) is a medicine in the xanthine oxidase inhibitor class. It lowers uric acid levels by blocking xanthine oxidase, an enzyme involved in uric acid production.

What is it used for?

Drugs in the febuxostat (xanthine oxidase inhibitor) class are used to treat hyperuricemia and gout—conditions where uric acid builds up and crystals form in joints or tissues.

How does it work compared with allopurinol?

Febuxostat and allopurinol are both xanthine oxidase inhibitors. The key difference is the specific active ingredient (febuxostat vs. allopurinol), but the shared mechanism is uric acid reduction through xanthine oxidase inhibition.

Is febuxostat an “acute gout attack” medicine?

Xanthine oxidase inhibitors like febuxostat are primarily used for long-term urate lowering (prevention/control of gout). They are not typically used to treat an active acute flare as a first-line, immediate anti-inflammatory therapy.

Where to check patent/drug coverage information

For drug-specific patent or market-authorization coverage details, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/